United States Government Publishing Office publisher pbl distributor dst United States Congress Senate Committee on Finance (Senate) author aut Government Organization text government publication eng GOVPUB Congressional Committee Materials legislative 2023-09-01 Congress 2005-01-01 monographic harvested born digital 61 digital object pages Y 4.F 49:S.HRG.108-791 https://www.govinfo.gov/app/details/GOVPUB-Y4_F49-PURL-LPS75299 P0b002ee1beace6a5 000589804 https://purl.fdlp.gov/GPO/LPS75299 (OCoLC)63031273 DGPO 2023-09-01 2026-06-30 GOVPUB-Y4_F49-PURL-LPS75299 machine generated eng fdlp Y4_F49 GOVPUB-Y4_F49-PURL-LPS75299 PURL-LPS75299 GOVPUB;CHRG This content was harvested from online sources of the original hosting or authoring agency and may not reflect current policy. As Federal agencies add publications to their websites, or report new publications to GPO per statutory mandate (44 U.S.C. §§ 1710, 1902-1903), GPO ensures long-term preservation of and access to the content. 2005 PERM_INGEST_04282022 LPS75299 Committee on Finance Finance https://www.govinfo.gov/app/details/GOVPUB-Y4_F49-PURL-LPS75299 https://www.govinfo.gov/content/pkg/GOVPUB-Y4_F49-PURL-LPS75299/pdf/GOVPUB-Y4_F49-PURL-LPS75299.pdf Putting Patient Safety First? : Hearing Before the Committee on Finance, United States Senate, One Hundred Eighth Congress, Second Session, November 18, 2004 Corrupt practices Drug monitoring Drugs Rofecoxib Testing United States Merck & Co. United States Congress. Senate. Committee on Finance. creator dcu U.S. G.P.O. 2005. monographic

print

iv, 921 pages : illustrations ; 23 cm. KF26 .F5 2004v Y 4.F 49:S.HRG.108-791 text bibliography eng This document has been withdrawn from the federal depository library program at the request of the publishing agency on 6/20/06. Includes bibliographical references. Statements of committee chairs and testimony of expert witnesses also available via Internet from the GPO permanent archive. Address as of 10/25/06: http://permanent.access.gpo.gov/lps75299/merckvioxx.pdf; current access available via PURL. n-us--- Rofecoxib Merck & Co. Corrupt practices Drug monitoring United States Drugs United States Testing United States. Congress. Senate. https://purl.fdlp.gov/GPO/LPS75299 putting patient safety first? : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, November 18, 2004 putting patient safety first? : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, November 18, 2004